Fundz

Dechert Advises Abivax On Its Successful €49.2 Million Financing

PRIVATESep 02, 2022

Amount Raised

€49.2 Million

Round Type

Funding Round

New YorkBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalConsultingLegalBiopharma

Description

Dechert advised Abivax on its successful €49.2 million financing with top U.S. and European biotech specialist investors. The financing was underwritten by new and existing biotech investors based in the U.S. and Europe and led by TCGX, with participation from Venrock Healthcare Capital Partners, Deep Track Capital, Sofinnova Partners, Invus and Truffle Capital.

Quick answer

Abivax raised €49.2 Million in a Funding Round round, dated September 2, 2022. Abivax is based in New York, United States.

How much did Abivax raise?
Abivax raised €49.2 Million in a Funding Round round on September 2, 2022.
What does Abivax do?
Abivax is developing therapies that modulate the body’s natural immune system machinery.
Where is Abivax based and how big is it?
Abivax is based in New York, United States.
Who are the decision-makers at Abivax?
Fundz holds 3 contacts at Abivax, including the Chief Business Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Abivax that raised within 45 days of this round, from Fundz verified event records.

  • LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
  • Qnovia raised $17M (Series A) on September 28, 2022.
  • CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
  • SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
  • Pharnext raised an undisclosed amount (Debt Financing) on October 3, 2022.
  • Gamida Cell raised $25M (Funding Round) on September 28, 2022.

Who to call at Abivax, and when

A new round usually means Abivax is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Abivax raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Abivax, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Abivax. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Abivax

Location

Rue De La Baume

New York, United States

About

Abivax is developing therapies that modulate the body’s natural immune system machinery. A clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to develop drug candidates to treat inflammatory diseases, viral diseases and liver cancer. Abivax is based on innovative research driven by the idea of modulating the body’s natural immune system mechanisms to treat diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Abivax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsPierre C., Chief Business Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Abivax's next move

See what Strategic adds

Abivax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.